ChromoGenics is granted a deferment of its repayment obligation
The Swedish Energy Agency (”Energimyndigheten”) grants ChromoGenics AB a deferment of its repayment obligation including amortization and interest on the conditional loan until October 1st 2025.
ChromoGenics has applied for a deferment of its repayment obligation of amortization and interest on the conditional loans to the Swedish Energy Agency. The conditional loan was granted for ChromoGenics pilot project, ConverLight 36700-1.
The granted deferment from the Swedish Energy Agency is valid until October 1st 2025. The decision is subject to a condition stating that an additional status update and reporting shall be done in August 2024, at which point the Swedish Energy Agency has the right to reconsider the decision. The granted deferment is not specified by amount.
This information constitutes such information that ChromoGenics AB (publ) is obligated to disclose in accordance with the EU Market Abuse Regulation. The information was submitted by the above-mentioned contact persons for publication on 5 October 2022, at 17:25 CET.
Every care has been taken in the translation of this document. In the event of discrepancies, the Swedish original will supersede the English translation.
ChromoGenics is a PropTech company that produces dynamic glass for real estate. One company product, ConverLight® Dynamic, controls indoor comfort by optimising daylighting, good views and blocking solar heat, and thereby contributing to reducing costs for cooling. ConverLight® Dynamic is based on a patented solution where electrochromic coatings are sputtered onto plastic film and then laminated between glass layers. The plastic film is easy to transport which means long distance shipping of bulky glass can be avoided. ChromoGenics also offers ConverLight® Static, a static glass version, and a façade glazing solution, ConverLight® Energy. ChromoGenics has supplied glazing technology to a large number of major real estate companies. Its shares were listed on the Nasdaq First North Growth Market in 2017.
The company’s production site in Uppsala has been partly financed via conditional loans from the Swedish Energy Agency. ChromoGenics shares (CHRO) are listed on the Nasdaq First North Growth Market with Erik Penser Bank as Certified Adviser: firstname.lastname@example.org, +46 (0)8 463 83 00.